Author:
Haider Marie-Therese,Hunter Keith D.,Robinson Simon P.,Graham Timothy J.,Corey Eva,Dear T. Neil,Hughes Russell,Brown Nicola J.,Holen Ingunn
Funder
Exelixis, Inc.
Breast Cancer Campaign (UK)
CR-UK Imaging Centre
Subject
Histology,Physiology,Endocrinology, Diabetes and Metabolism
Reference48 articles.
1. Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth;Yakes;Mol. Cancer Ther.,2011
2. Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro;Grano;Proc. Natl. Acad. Sci. U. S. A.,1996
3. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation;Deckers;Endocrinology,2000
4. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation;Gerber;Nat. Med.,1999
5. Preclinical evaluation of imaging biomarkers for prostate cancer bone metastasis and response to cabozantinib;Graham;J. Natl. Cancer Inst.,2014
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献